<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04340310</url>
  </required_header>
  <id_info>
    <org_study_id>CEIC (HUSJ-20-003)</org_study_id>
    <nct_id>NCT04340310</nct_id>
  </id_info>
  <brief_title>Home Respiratory Polygraphy in Childhood Sleep Apnea-Hypopnea Syndrome (CHILDSLEEP).</brief_title>
  <acronym>CHILDSLEEP</acronym>
  <official_title>Usefulness of Home Respiratory Polygraphy in the Diagnosis and Therapeutic Decision of Childhood Sleep Apnea-Hypopnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario San Juan de Alicante</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario San Juan de Alicante</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the study is to assess the diagnostic utility of home respiratory polygraphy
      (HRP) complemented with polysomnography (PSG) in childhood Obstructive Sleep Apnea-Hypopnea
      Syndrome (OSAS), as well as its usefulness in the therapeutic decisions.

      Methods: Children referred with suspected OSAS will be evaluated during one year performing
      home respiratory polygraphy in all cases. PSG will be chosen in patients with concomitant
      pathology or according to medical criteria, or complemented with HRP in doubtful cases.
      Clinical and anthropometric data, severity, technical quality and treatment will be obtained.
      Patients will be divided in two groups (HRP vs PSG) and compared, and the accuracy from HRP
      to establish a therapeutic decision it wil calculated. The investigator's hypothesis is that
      PSG should be recommended only for complex or doubtful cases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2019</start_date>
  <completion_date type="Anticipated">April 6, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>To assess the diagnostic utility of home respiratory polygraphy (HRP) complemented with polysomnography (PSG) in childhood Obstructive Sleep Apnea-Hypopnea Syndrome (OSAS), as well as its usefulness in the therapeutic decisions.</measure>
    <time_frame>two years</time_frame>
    <description>False negative and true positive diagnosis by home respiratory polygraphy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the prevalence of childhood sleep apnea in Pneumology hospital consultations</measure>
    <time_frame>two years</time_frame>
    <description>Number of chlidhood sleep consultations related to adult consultations</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Home Respiratory Polygraphy Sleep Study</condition>
  <condition>Childhood Sleep Apnea</condition>
  <condition>Polysomnography</condition>
  <condition>Therapeutic Decision</condition>
  <arm_group>
    <arm_group_label>Home respiratory poligraphy</arm_group_label>
    <description>Group A: Children between 4 and 14 years-old with initial OSA suspicion there will be allocated to Home Respiratory Polygraphy (HRP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polysomnography</arm_group_label>
    <description>Group B: Children between 4 and 14 years-old with initial OSA suspicion and concommitant diseases and false negative suspicion from HRP there will allocated to Hospital Nocturnal Polysomnography</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Home respiratory polygraphy</intervention_name>
    <description>Home respiratory polygraphy or Polysomnography to stablish a therapeutic decission</description>
    <arm_group_label>Home respiratory poligraphy</arm_group_label>
    <arm_group_label>Polysomnography</arm_group_label>
    <other_name>Polysomnography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children submited to Pneumology Service with sleep apnea suspicion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sleep apnea suspicion

        Exclusion Criteria:

          -  Other sleep conditions

          -  Non valid home respiratory polygraphy and non valid polysomnography in the same
             patient

          -  Non informated consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Eusebi Chiner Vives</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario San Juan de Alicante</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eusebi Chiner Vives, MD, PhD</last_name>
    <phone>609017275</phone>
    <email>echinervives@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eusebio Chiner Vives</name>
      <address>
        <city>San Juan de Alicante</city>
        <state>Alicante</state>
        <zip>03550</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eusebi Chiner-Vives, MD, PhD</last_name>
      <phone>+34699445131</phone>
      <email>echinervives@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Cistina CÃ¡novas-Galindo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario San Juan de Alicante</investigator_affiliation>
    <investigator_full_name>Eusebi Chiner</investigator_full_name>
    <investigator_title>Head of Pneumology</investigator_title>
  </responsible_party>
  <keyword>Childhood sleep apnea</keyword>
  <keyword>Sleep apnea syndrome</keyword>
  <keyword>Obstructive apnea syndrome</keyword>
  <keyword>Obstructive apnea sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Scientific publication, Sleep spanish network</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>5 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

